ESCITALOPRAM
- Product NDC
- 69844-035
- 11-digit product format
- 698440035
- Labeler code
- 69844
- Product ID
- 69844-035_b17f059d-46ae-4160-9c55-7251ad243e30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ESCITALOPRAM OXALATE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Graviti Pharmaceuticals Private Limited
- Application
- ANDA078777
- Marketing category
- ANDA
- Marketing start
- 2019-11-14
- Marketing end
- 0000-00-00
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69844-035-01 | 69844003501 | 30 TABLET, FILM COATED in 1 BOTTLE (69844-035-01) | 2019-11-14 | 0000-00-00 | No | No | Current |
| 69844-035-02 | 69844003502 | 100 TABLET, FILM COATED in 1 BOTTLE (69844-035-02) | 2019-11-14 | 0000-00-00 | No | No | Current |
| 69844-035-03 | 69844003503 | 1000 TABLET, FILM COATED in 1 BOTTLE (69844-035-03) | 2019-11-14 | 0000-00-00 | No | No | Current |